In addition, results from some trials on adenomyosis showed that applying gonadotrophin-releasing hormone agonists (GnRH-a) before IVF/ICSI cycle exerts positive effects on increasing the clinical pregnancy rate in patients with adenomyosis (11–13). Here, GNRH1 is linked to adenomyosis.